Primary data from DESTINY-Lung01: A phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Li, B. T.; Smit, E. F. F.; Goto, Y.; Nakagawa, K.; Udagawa, H.; Mazieres, J.; Nagasaka, M.; Bazhenova, L.; Saltos, A. N.; Felip, E.; Pacheco, J. M.; Pérol, M.; Paz-Ares, L.; Saxena, K.; Shiga, R.; Cheng, Y.; Acharyya, S.; Shahidi, J.; Planchard, D.; Jänne, P. A. |
| Abstract Title: | Primary data from DESTINY-Lung01: A phase II trial of trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S1323 |
| End Page: | S1324 |
| Language: | English |
| ACCESSION: | WOS:000700527704003 |
| DOI: | 10.1016/j.annonc.2021.08.2124 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA45 -- Source: Wos |
